SCHEMBL8169121

SCHEMBL8169121

CCCCOc1ccc(-c2[c]ccc(C(=N)N)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 11/20 0.49
TMPRSS2 O15393 2/20 0.49
PRMT1 Q99873 3/20 0.48
F2 P00734 3/20 0.48
ST14 Q9Y5Y6 2/20 0.48
PLG P00747 2/20 0.48
PLAU P00749 1/20 0.48
PRMT5 O14744 1/20 0.48
SLC22A2 O15244 1/20 0.48
SLC22A1 O15245 1/20 0.48
PTP4A3 O75365 1/20 0.48
SLC22A3 O75751 1/20 0.48
F10 P00742 1/20 0.48
S100B P04271 1/20 0.48
CHRM2 P08172 1/20 0.48
CHRM4 P08173 1/20 0.48
CHRM5 P08912 1/20 0.48
ADRA2A P08913 1/20 0.48
CYP2D6 P10635 1/20 0.48
AOC1 P19801 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8163067 0.82 PRSS1 (0.54) PRSS1F2ST14PLGPLAU
SCHEMBL8176603 0.79 NQO2 (0.48) PRSS1PRMT1F2PLGPLAU
SCHEMBL8007736 0.77 CYP19A1 (0.48) CYP2D6
SCHEMBL8170510 0.77 NQO2 (0.44) PRSS1PRMT1F2PLGPLAU
SCHEMBL9650651 0.76 PRSS1 (0.81) PRSS1TMPRSS2PRMT1F2ST14
SCHEMBL9783835 0.76 NR5A1 (0.50) CYP2D6
SCHEMBL11016291 0.75 LTA4H (0.53) CYP2D6
Hydrochloric Acid SCHEMBL11182186 0.75 PRSS1 (0.82) PRSS1TMPRSS2PRMT1F2ST14
Hydrochloric Acid SCHEMBL7796572 0.75 PRSS1 (0.75) PRSS1TMPRSS2PRMT1F2ST14
SCHEMBL8169720 0.74 C1S (0.44) PRSS1PRMT1F2ST14PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114328-A ANTICOAGULANTS; BLOOD DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-09-05 US disclosed
US-5849736-A Isoxazoline and isoxazole fibrinogen receptor antagonists THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-15 US disclosed